-
1
-
-
1942505811
-
Disorders of bilirubin metabolism
-
I.M. Arias J.L. Boyer F.V. Chisari 4th ed. Lippincott Williams & Wilkins Philadelphia *et al.
-
N. Roy Chowdhury, I.M. Arias, A.W. Wolkoff Disorders of bilirubin metabolism I.M. Arias J.L. Boyer F.V. Chisari The liver biology and pathobiology 4th ed. 2001 Lippincott Williams & Wilkins Philadelphia 291 309
-
(2001)
The Liver: Biology and Pathobiology
, pp. 291-309
-
-
Roy Chowdhury, N.1
Arias, I.M.2
Wolkoff, A.W.3
-
2
-
-
0014608853
-
Studies of bilirubin kinetics in normal adults
-
P. Berk, R. Howe, J. Bloomer Studies of bilirubin kinetics in normal adults J Clin Invest 48 1969 2176 2190
-
(1969)
J Clin Invest
, vol.48
, pp. 2176-2190
-
-
Berk, P.1
Howe, R.2
Bloomer, J.3
-
3
-
-
4644360662
-
Bilirubin metabolism and the hyperbilirubinemias
-
E. Braunwald A.S. Fauci D.L. Kasper 15th ed. McGraw-Hill New York *et al.
-
P.D. Berk, A.W. Wolkoff Bilirubin metabolism and the hyperbilirubinemias E. Braunwald A.S. Fauci D.L. Kasper Harrison's principles of internal medicine 15th ed. 2001 McGraw-Hill New York 1715 1720
-
(2001)
Harrison's Principles of Internal Medicine
, pp. 1715-1720
-
-
Berk, P.D.1
Wolkoff, A.W.2
-
4
-
-
0033574696
-
Unconjugated bilirubin exhibits spontaneous diffusion through model lipid bilayers and native hepatocyte membranes
-
S. Zucker, W. Goessling, A. Hoppin Unconjugated bilirubin exhibits spontaneous diffusion through model lipid bilayers and native hepatocyte membranes J Biol Chem 274 1999 10852 10862
-
(1999)
J Biol Chem
, vol.274
, pp. 10852-10862
-
-
Zucker, S.1
Goessling, W.2
Hoppin, A.3
-
5
-
-
0026701911
-
A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini
-
J.K. Ritter, F. Chen, Y.Y. Sheen A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini J Biol Chem 267 1992 3257 3261
-
(1992)
J Biol Chem
, vol.267
, pp. 3257-3261
-
-
Ritter, J.K.1
Chen, F.2
Sheen, Y.Y.3
-
6
-
-
0028276410
-
Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man
-
P.J. Bosma, J. Seppen, B. Goldhoorn Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man J Biol Chem 269 1994 17960 17964
-
(1994)
J Biol Chem
, vol.269
, pp. 17960-17964
-
-
Bosma, P.J.1
Seppen, J.2
Goldhoorn, B.3
-
7
-
-
0028960244
-
ATP-dependent transport systems in the canalicular membrane of the hepatocyte
-
Z.C. Gatmaitan, I.M. Arias ATP-dependent transport systems in the canalicular membrane of the hepatocyte Physiol Rev 75 1995 261 275
-
(1995)
Physiol Rev
, vol.75
, pp. 261-275
-
-
Gatmaitan, Z.C.1
Arias, I.M.2
-
8
-
-
0036648878
-
Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes
-
S. Kikuchi, M. Hata, K. Fukumoto Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes Nat Genet 31 2002 320 325
-
(2002)
Nat Genet
, vol.31
, pp. 320-325
-
-
Kikuchi, S.1
Hata, M.2
Fukumoto, K.3
-
9
-
-
0029986408
-
Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome
-
J. Kartenbeck, U. Leuschner, R. Mayer Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome Hepatology 23 1996 1061 1066
-
(1996)
Hepatology
, vol.23
, pp. 1061-1066
-
-
Kartenbeck, J.1
Leuschner, U.2
Mayer, R.3
-
10
-
-
0016807428
-
Unconjugated hyperbilirubinemia: Physiologic evaluation and experimental approaches to therapy
-
P.D. Berk, J.F. Martin, T.F. Blaschke Unconjugated hyperbilirubinemia physiologic evaluation and experimental approaches to therapy Ann Intern Med 82 1975 552 570
-
(1975)
Ann Intern Med
, vol.82
, pp. 552-570
-
-
Berk, P.D.1
Martin, J.F.2
Blaschke, T.F.3
-
11
-
-
16844373828
-
Approach to the patient with jaundice or abnormal liver tests
-
L. Goldman D.W. Powell J.M. Drazen 22nd ed. WB Saunders Philadelphia *et al.
-
P.D. Berk Approach to the patient with jaundice or abnormal liver tests L. Goldman D.W. Powell J.M. Drazen Cecil's textbook of medicine 22nd ed. 2004 WB Saunders Philadelphia 897 906
-
(2004)
Cecil's Textbook of Medicine
, pp. 897-906
-
-
Berk, P.D.1
-
12
-
-
0025812442
-
Investigation of the molecular basis of the genetic deficiency of UDP-glucuronosyl-transferase in Crigler-Najjar syndrome
-
K.J. Robertson, D. Clarke, L. Sutherland Investigation of the molecular basis of the genetic deficiency of UDP-glucuronosyl-transferase in Crigler-Najjar syndrome J Inherit Metab Dis 14 1991 563 579
-
(1991)
J Inherit Metab Dis
, vol.14
, pp. 563-579
-
-
Robertson, K.J.1
Clarke, D.2
Sutherland, L.3
-
13
-
-
0014852793
-
Constitutional hepatic dysfunction (Gilbert's syndrome): A new definition based on kinetic studies with unconjugated radiobilirubin
-
P.D. Berk, J.R. Bloomer, R.B. Howe Constitutional hepatic dysfunction (Gilbert's syndrome) a new definition based on kinetic studies with unconjugated radiobilirubin Am J Med 49 1970 296 305
-
(1970)
Am J Med
, vol.49
, pp. 296-305
-
-
Berk, P.D.1
Bloomer, J.R.2
Howe, R.B.3
-
14
-
-
0032847365
-
Molecular genetic basis of Gilbert's syndrome
-
B. Burchell, R. Hume Molecular genetic basis of Gilbert's syndrome J Gastroenterol Hepatol 14 1999 960 966
-
(1999)
J Gastroenterol Hepatol
, vol.14
, pp. 960-966
-
-
Burchell, B.1
Hume, R.2
-
15
-
-
0033753524
-
Genetic defects in hepatocanalicular transport
-
R. Thompson, P.L. Jansen Genetic defects in hepatocanalicular transport Semin Liver Dis 20 2000 365 372
-
(2000)
Semin Liver Dis
, vol.20
, pp. 365-372
-
-
Thompson, R.1
Jansen, P.L.2
-
16
-
-
0033823495
-
Infections of the liver in HIV-infected patients
-
M.A. Poles, D.T. Dieterich Infections of the liver in HIV-infected patients Infect Dis Clin North Am 14 2000 741 759
-
(2000)
Infect Dis Clin North Am
, vol.14
, pp. 741-759
-
-
Poles, M.A.1
Dieterich, D.T.2
-
17
-
-
0242605180
-
Evaluation of liver function and injury
-
J.B. Henry 20th ed. WB Saunders Philadelphia
-
D.R. Dufour Evaluation of liver function and injury J.B. Henry Clinical diagnosis and management by laboratory methods 20th ed. 2001 WB Saunders Philadelphia 264 280
-
(2001)
Clinical Diagnosis and Management by Laboratory Methods
, pp. 264-280
-
-
Dufour, D.R.1
-
18
-
-
0034606721
-
Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection
-
M.S. Sulkowski, D.L. Thomas, R.E. Chaisson Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection JAMA 283 2000 74 80
-
(2000)
JAMA
, vol.283
, pp. 74-80
-
-
Sulkowski, M.S.1
Thomas, D.L.2
Chaisson, R.E.3
-
19
-
-
0037945498
-
Human immunodeficiency virus and the liver: Lessons learned and still to be learned
-
D.T. Dieterich Human immunodeficiency virus and the liver lessons learned and still to be learned Semin Liver Dis 23 2003 107 114
-
(2003)
Semin Liver Dis
, vol.23
, pp. 107-114
-
-
Dieterich, D.T.1
-
20
-
-
0003730884
-
-
AIDS Clinical Trials Group National Institute of Allergy and Infectious Diseases, Division of AIDS Rockville, MD
-
AIDS Clinical Trials Group Table of grading severity of adult adverse experiences 1996 National Institute of Allergy and Infectious Diseases, Division of AIDS Rockville, MD
-
(1996)
Table of Grading Severity of Adult Adverse Experiences
-
-
-
21
-
-
0038621633
-
Hepatotoxicity of nucleoside reverse transcriptase inhibitors
-
V. Montessori, M. Harris, J.S. Montaner Hepatotoxicity of nucleoside reverse transcriptase inhibitors Semin Liver Dis 23 2003 167 172
-
(2003)
Semin Liver Dis
, vol.23
, pp. 167-172
-
-
Montessori, V.1
Harris, M.2
Montaner, J.S.3
-
22
-
-
0028990381
-
Mitochondrial toxicity of antiviral drugs
-
W. Lewis, M.C. Dalakas Mitochondrial toxicity of antiviral drugs Nat Med 1 1995 417 422
-
(1995)
Nat Med
, vol.1
, pp. 417-422
-
-
Lewis, W.1
Dalakas, M.C.2
-
23
-
-
0037369839
-
Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitors
-
A.M. Martin, E. Hammond, D. Nolan Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitors Am J Hum Genet 72 2003 549 560
-
(2003)
Am J Hum Genet
, vol.72
, pp. 549-560
-
-
Martin, A.M.1
Hammond, E.2
Nolan, D.3
-
24
-
-
0025835105
-
Fulminant hepatic failure associated with 2',3'-dideoxyinosine (ddI)
-
K.K. Lai, D.L. Gang, J.K. Zawacki Fulminant hepatic failure associated with 2',3'-dideoxyinosine (ddI) Ann Intern Med 115 1991 283 284
-
(1991)
Ann Intern Med
, vol.115
, pp. 283-284
-
-
Lai, K.K.1
Gang, D.L.2
Zawacki, J.K.3
-
25
-
-
0032450165
-
DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy
-
Y. Bourezane, D. Salard, B. Hoen DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy Clin Infect Dis 27 1998 1321 1322
-
(1998)
Clin Infect Dis
, vol.27
, pp. 1321-1322
-
-
Bourezane, Y.1
Salard, D.2
Hoen, B.3
-
26
-
-
0000544290
-
Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures: Worldwide, 1997-2000
-
Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures worldwide, 1997-2000 MMWR Morb Mortal Wkly Rep 49 2001 1153 1156
-
(2001)
MMWR Morb Mortal Wkly Rep
, vol.49
, pp. 1153-1156
-
-
-
27
-
-
0036139688
-
Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections
-
M.S. Sulkowski, D.L. Thomas, S.H. Mehta Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy role of hepatitis C and B infections Hepatology 35 2002 182 189
-
(2002)
Hepatology
, vol.35
, pp. 182-189
-
-
Sulkowski, M.S.1
Thomas, D.L.2
Mehta, S.H.3
-
28
-
-
0036535126
-
Lack of hepatotoxicity associated with nonnucleoside reverse transcriptase inhibitors
-
R. Palmon, B.C. Koo, D.A. Shoultz Lack of hepatotoxicity associated with nonnucleoside reverse transcriptase inhibitors J Acquir Immune Defic Syndr 29 2002 340 345
-
(2002)
J Acquir Immune Defic Syndr
, vol.29
, pp. 340-345
-
-
Palmon, R.1
Koo, B.C.2
Shoultz, D.A.3
-
29
-
-
0037945435
-
Toxicity of non-nucleoside analogue reverse transcriptase inhibitors
-
N. Kontorinis, D.T. Dieterich Toxicity of non-nucleoside analogue reverse transcriptase inhibitors Semin Liver Dis 23 2003 173 182
-
(2003)
Semin Liver Dis
, vol.23
, pp. 173-182
-
-
Kontorinis, N.1
Dieterich, D.T.2
-
30
-
-
0033401920
-
Indinavir: A review of its use in the management of HIV infection
-
G.L. Plosker, S. Noble Indinavir a review of its use in the management of HIV infection Drugs 58 1999 1165 1203
-
(1999)
Drugs
, vol.58
, pp. 1165-1203
-
-
Plosker, G.L.1
Noble, S.2
-
31
-
-
0038621557
-
Hepatotoxicity associated with antiretroviral therapy containing HIV-1 protease inhibitors
-
M.S. Sulkowski Hepatotoxicity associated with antiretroviral therapy containing HIV-1 protease inhibitors Semin Liver Dis 23 2003 183 194
-
(2003)
Semin Liver Dis
, vol.23
, pp. 183-194
-
-
Sulkowski, M.S.1
-
32
-
-
0034760885
-
Symptomatic hyperbilirubinemia with indinavir/ritonavir-containing regimen
-
C.R. Rayner, L.D. Esch, H.E. Wynn Symptomatic hyperbilirubinemia with indinavir/ritonavir-containing regimen Ann Pharmacother 35 2001 1391 1395
-
(2001)
Ann Pharmacother
, vol.35
, pp. 1391-1395
-
-
Rayner, C.R.1
Esch, L.D.2
Wynn, H.E.3
-
34
-
-
0037234238
-
Results of a phase 2 clinical trial at 48 weeks (AI424-007): A dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects
-
I. Sanne, P. Piliero, K. Squires Results of a phase 2 clinical trial at 48 weeks (AI424-007) a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects J Acquir Immune Defic Syndr 32 2003 18 29
-
(2003)
J Acquir Immune Defic Syndr
, vol.32
, pp. 18-29
-
-
Sanne, I.1
Piliero, P.2
Squires, K.3
-
35
-
-
0037661234
-
Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: A randomized comparative pilot trial
-
D.W. Haas, C. Zala, S. Schrader Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy a randomized comparative pilot trial AIDS 17 2003 1339 1349
-
(2003)
AIDS
, vol.17
, pp. 1339-1349
-
-
Haas, D.W.1
Zala, C.2
Schrader, S.3
-
36
-
-
16944362657
-
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: Results of a phase II study--National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group
-
R.J. Whitley, G. Cloud, W. Gruber Ganciclovir treatment of symptomatic congenital cytomegalovirus infection results of a phase II study--National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group J Infect Dis 175 1997 1080 1086
-
(1997)
J Infect Dis
, vol.175
, pp. 1080-1086
-
-
Whitley, R.J.1
Cloud, G.2
Gruber, W.3
-
37
-
-
0030821610
-
Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: Risk factors and outcome
-
B. Salzberger, R.A. Bowden, R.C. Hackman Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease risk factors and outcome Blood 90 1997 2502 2508
-
(1997)
Blood
, vol.90
, pp. 2502-2508
-
-
Salzberger, B.1
Bowden, R.A.2
Hackman, R.C.3
-
38
-
-
0032547938
-
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C: Hepatitis Interventional Therapy Group
-
J.G. McHutchison, S.C. Gordon, E.R. Schiff Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C Hepatitis Interventional Therapy Group N Engl J Med 339 1998 1485 1492
-
(1998)
N Engl J Med
, vol.339
, pp. 1485-1492
-
-
McHutchison, J.G.1
Gordon, S.C.2
Schiff, E.R.3
-
39
-
-
0032547944
-
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C: International Hepatitis Interventional Therapy Group
-
G.L. Davis, R. Esteban-Mur, V. Rustgi Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C International Hepatitis Interventional Therapy Group N Engl J Med 339 1998 1493 1499
-
(1998)
N Engl J Med
, vol.339
, pp. 1493-1499
-
-
Davis, G.L.1
Esteban-Mur, R.2
Rustgi, V.3
-
40
-
-
0036252557
-
Treatment of hepatitis C and anemia in human immunodeficiency virus-infected patients
-
D.T. Dieterich Treatment of hepatitis C and anemia in human immunodeficiency virus-infected patients J Infect Dis 185 Suppl 2 2002 S128 S137
-
(2002)
J Infect Dis
, vol.185
, Issue.2 SUPPL.
-
-
Dieterich, D.T.1
|